A detailed history of Cormorant Asset Management, LP transactions in Insmed Inc stock. As of the latest transaction made, Cormorant Asset Management, LP holds 500,000 shares of INSM stock, worth $33.1 Million. This represents 2.56% of its overall portfolio holdings.

Number of Shares
500,000
Previous 675,000 25.93%
Holding current value
$33.1 Million
Previous $45.2 Million 19.29%
% of portfolio
2.56%
Previous 3.48%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$62.0 - $79.01 $10.9 Million - $13.8 Million
-175,000 Reduced 25.93%
500,000 $36.5 Million
Q2 2024

Aug 14, 2024

BUY
$22.0 - $69.71 $2.2 Million - $6.97 Million
100,000 Added 17.39%
675,000 $45.2 Million
Q3 2023

Nov 14, 2023

BUY
$19.86 - $26.93 $11.4 Million - $15.5 Million
575,000 New
575,000 $14.5 Million
Q3 2021

Nov 15, 2021

SELL
$22.46 - $29.47 $5.62 Million - $7.37 Million
-250,000 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$24.17 - $36.01 $1.21 Million - $1.8 Million
-50,000 Reduced 16.67%
250,000 $7.12 Million
Q4 2020

Feb 16, 2021

SELL
$31.45 - $40.54 $1.57 Million - $2.03 Million
-50,000 Reduced 14.29%
300,000 $9.99 Million
Q3 2020

Nov 16, 2020

SELL
$26.0 - $34.5 $2.6 Million - $3.45 Million
-100,000 Reduced 22.22%
350,000 $11.2 Million
Q2 2020

Aug 14, 2020

BUY
$14.11 - $29.42 $1.24 Million - $2.58 Million
87,727 Added 24.22%
450,000 $12.4 Million
Q1 2020

May 15, 2020

BUY
$13.63 - $33.98 $4.94 Million - $12.3 Million
362,273 New
362,273 $5.81 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $8.98B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Cormorant Asset Management, LP Portfolio

Follow Cormorant Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cormorant Asset Management, LP with notifications on news.